COMMUNIQUÉS West-GlobeNewswire
-
Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference
28/07/2026 -
Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days
28/07/2026 -
Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce
28/07/2026 -
Slate Medicines Establishes Clinical and Scientific Advisory Boards to Advance Next-Generation Migraine Prevention Therapeutics
28/07/2026 -
Cato Healthcare Supply Strengthens Executive Leadership Team
28/07/2026 -
CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference
28/07/2026 -
CorVascular Named Exclusive U.S. Importer and Vascular Distributor for ASUS FDA-Cleared Ultrasound Portfolio
28/07/2026 -
AGC Biologics Lands Commercial Manufacturing Agreement for Yokohama Site Worth Hundreds of Millions of Dollars
28/07/2026 -
Transactions in connection with share buy-back program
28/07/2026 -
ProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial
28/07/2026 -
Promatix Biosciences Awarded Innovate UK Biomedical Catalyst Grant to Advance First-in-Class EGFR × EphA2 Cis-Bispecific ADC
28/07/2026 -
Xeltis raises an additional €20.5m of funding to advance aXess™ toward FDA approval and US commercial launch
28/07/2026 -
Aqua free soutient un projet d’accès à l’eau potable en Tanzanie
28/07/2026 -
Tensive reports pivotal 12-month clinical trial data confirming REGENERA™ delivers natural breast reconstruction after lumpectomy
28/07/2026 -
Aqua free Supports Drinking Water Project in Tanzania
28/07/2026 -
Rapid Nutrition Expands Owned-Brand Portfolio Through AI-Driven Commercial Intelligence
28/07/2026 -
BurnTide Launch 2026: New Weight Loss Support ACV Gummies In The USA, AU, UK | Burntide Supplement Facts And Highlights Ingredients.
28/07/2026 -
ARCPOINT PROVIDES UPDATE ON MANAGEMENT CEASE TRADE ORDER APPLICATION AND DELAY IN FILING ANNUAL FINANCIAL STATEMENTS
28/07/2026 -
Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
27/07/2026
Pages